The effect of sepsis and its inflammatory response on mechanical clot characteristics: a prospective observational study
- 899 Downloads
Sepsis and its progression are known to have a major influence on the coagulation system. Current coagulation tests are of limited use when assessing coagulation in sepsis patients. This study aims to assess the potential for a new functional biomarker of clot microstructure, fractal dimension, to identify changes in the mechanical properties of clot microstructure across the sepsis spectrum (sepsis, severe sepsis and septic shock).
A total of 100 patients that presented acutely to a large teaching hospital were included in this prospective observational study (50 sepsis, 20 severe sepsis and 30 septic shock) against a matched control of 44 healthy volunteers. Fractal analysis was performed, as well as standard markers of coagulation, and six plasma markers of inflammation.
Fractal dimension was significantly higher in the sepsis and severe sepsis groups than the healthy control (1.78 ± 0.07 and 1.80 ± 0.05, respectively vs 1.74 ± 0.03) (p < 0.001), indicating a significant increase in mechanical clot strength and elasticity consistent with a hypercoagulable state. Conversely, fractal dimension was significantly lower in septic shock (1.66 ± 0.10, p < 0.001), indicating a significant reduction in mechanical clot strength and functionality consistent with a hypocoagulable state. This corresponded with a significant increase in the inflammatory response.
This study confirms that clot microstructure is significantly altered through the various stages of sepsis. Of particular importance was the marked change in clot development between severe sepsis and septic shock, which has not been previously reported.
KeywordsSepsis Biomarkers Coagulation Clot microstructure
This study was funded by the National Institute for Social Care and Health Research (NISCHR) and was also part-funded by the European Social Fund (ESF) through the European Union’s Convergence programme administered by the Welsh Government. Our thanks go to the staff in the Emergency Department, Intensive Therapy Unit and Haemostasis Biomedical Research Unit of Morriston Hospital for their invaluable support.
Compliance with ethical standards
Conflicts of interest
PAE and PRW have signed the International Committee of Medical Journal Editors (ICMJE) form for declaration of interest and have declared all conflict of interests. All other authors declare no competing conflicts of interest.
- 1.Schouten M, Wiersinga WJ, Levi M, Van Der Poll T (2006) Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 79:536–545Google Scholar
- 3.Ranieri VM, Thompson BT, Barie PS, Dhainaut J-F, Douglas IS, Finfer S, Gårdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064CrossRefPubMedGoogle Scholar
- 4.Rimmer E, Kumar A, Doucette S, Marshall J, Dial S, Gurka D, Dellinger RP, Sharma S, Penner C, Kramer A, Wood K, Ronald J, Kumar A, Turgeon AF, Houston DS, Zarychanski R (2012) Activated protein C and septic shock: a propensity-matched cohort study. Crit Care Med 40:2974–2981CrossRefPubMedGoogle Scholar
- 5.Abraham E, Opal S, Demeyer I, Lo A, Svoboda P, Laterre F, Simon S, Light B, Peckelsen C, De Deyne C, Percell SR, Shu V, Poole L, Creasey AA (2003) Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290:238–247CrossRefPubMedGoogle Scholar
- 10.Davies NA, Harrison NK, Morris RHK, Noble S, Lawrence MJ, DSilva LA, Broome L, Brown MR, Hawkins KM, Williams PR, Davidson S, Evans PA (2015) Fractal dimension (d f) as a new structural biomarker of clot microstructure in different stages of lung cancer. Thromb Haemost 114:1251–1259CrossRefPubMedGoogle Scholar
- 11.Stanford SN, Sabra A, DSilva LA, Lawrence M, Morris R, Storton S, Brown M, Evans V, Hawkins K, Williams P, Davidson SJ, Wani M, Potter JF, Evans PF (2015) The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: a prospective observational study. BMC Neurol 15:35CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Davies G, Pillai S, Mills G, Aubrey R, Morris K, Williams P, Evans P (2016) Fractal dimension: a new biomarker for quantifying clot microstructure in patients across the sepsis spectrum. Crit Care 20(Suppl 2):P031Google Scholar
- 13.Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W, Schein R, Sibbald W (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 20:864–874Google Scholar
- 20.Lawrence MJ, Kumar S, Hawkins K, Boden S, Rutt H, Mills G, Sabra A, Morris RHK, Davidson SJ, Badiei N, Brown MR, Williams PR, Evans PA (2014) A new structural biomarker that quantifies and predicts changes in clot strength and quality in a model of progressive haemodilution. Thromb Res 134:488–494CrossRefPubMedGoogle Scholar
- 21.Lawrence MJ, Sabra A, Thomas P, Obaid DR, DSilva LA, Morris RHK, Hawkins K, Brown MR, Williams PR, Davidson SJ, Chase AJ, Smith D, Evans PA (2015) Fractal dimension: a novel clot microstructure biomarker use in ST elevation myocardial infarction patients. Atherosclerosis 240:402–407CrossRefPubMedGoogle Scholar
- 28.Davies GR, Mills GM, Lawrence M, Battle C, Morris K, Hawkins K, Williams PR, Davidson S, Thomas D, Evans PA (2014) The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness. PLoS One 9:e108589CrossRefPubMedPubMedCentralGoogle Scholar
- 29.Annane D, Timsit JF, Mégarbane B, Martin C, Misset B, Mourvillier B, Siami S, Chagnon J-L, Constantin J-M, Petitpas F, Souweine B, Amathieu R, Forceville X, Charpentier C, Tesnière A, Chastre J, Bohe J, Colin G, Cariou A, Renault A, Brun-Buisson C, Bellissant E (2013) Recombinant human activated protein C for adults with septic shock: a randomized controlled trial. Am J Respir Crit Care Med 187:1091–1097CrossRefPubMedGoogle Scholar
- 30.Hvidt LN, Perner A (2012) High dosage of dextran 70 is associated with severe bleeding in patients admitted to the intensive care unit for septic shock. Dan Med J 59:1–5Google Scholar
- 32.Collet JP, Allali Y, Lesty C, Tanguy ML, Silvain J, Ankri A, Blanchet B, Dumaine R, Gianetti J, Payot L, Weisel JW, Montalescot G (2006) Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 26:2567–2573CrossRefPubMedGoogle Scholar